会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • Diaryl ether cycloalkanes
    • 二芳基醚环烷烃
    • EP0409414A1
    • 1991-01-23
    • EP90306766.8
    • 1990-06-20
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Edwards, Philip NeilBird, Thomas Geoffrey Colerick
    • C07C323/18A61K31/10
    • C07C323/18
    • The invention concerns a diaryl ether cycloalkane of the formula I, or a pharmaceutically-acceptable salt thereof,
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      X¹ is oxy, thio, sulphinyl or sulphonyl;
      Ar² is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms;
      R¹ is (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a (3-6C)alkylene group which defines an optionally substituted ring having 4 to 7 ring atoms.
      The invention also concerns processes for the manufacture of a diaryl ether cycloalkane of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said cycloalkane. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的二芳基醚环烷烃或其药学上可接受的盐,其中Ar 1是任选取代的苯基或萘基; X 1是氧,硫,亚磺酰基或磺酰基; Ar 2是任选取代的亚苯基或含有至多三个氮原子的6元杂环部分; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 并且R 2和R 3一起形成一个(3-6C)亚烷基,它定义了一个任选取代的具有4至7个环原子的环。 本发明还涉及制备式I的二芳基醚环烷烃或其药学上可接受的盐的方法和含有所述环烷烃的药物组合物。 本发明的化合物是5-脂氧合酶的抑制剂。
    • 4. 发明公开
    • Diaryl ether heterocycles
    • Diaryläther-Heterozyklen。
    • EP0409413A2
    • 1991-01-23
    • EP90306765.0
    • 1990-06-20
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Edwards, Philip NeilBird, Thomas Geoffrey Colerick
    • C07D309/10C07D409/12A61K31/35
    • C07D409/12C07D307/20C07D309/10
    • The invention concerns a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof,
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      X¹ is oxy, thio, sulphinyl or sulphonyl;
      Ar² is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms;
      R¹ is (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a group of the formula -A²-X²-A³- wherein each of A² and A³ is (1-4C)alkylene and X² is oxy, thio, sulphinyl, sulphonyl or imino.
      The invention also concerns processes for the manufacture of a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said heterocycle. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的二芳基醚杂环或其药学上可接受的盐,其中Ar 1是任选取代的苯基或萘基; X 1是氧基,硫基,亚磺酰基或磺酰基; Ar 2是任选取代的亚苯基,或含有至多三个氮原子的6-元杂环烯部分; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 并且R 2和R 3一起形成式-A 2 -X 2 -A 3 - 的基团,其中A 2和A 3各自为(1-4C )亚烷基,X 2是氧基,硫基,亚磺酰基,磺酰基或亚氨基。 本发明还涉及制备式I的二芳基醚杂环或其药学上可接受的盐以及含有所述杂环的药物组合物的方法。 本发明的化合物是5-脂氧合酶的抑制剂。
    • 10. 发明公开
    • Bicyclic derivatives
    • Bizyklische Derivate。
    • EP0410661A2
    • 1991-01-30
    • EP90308023.2
    • 1990-07-23
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Bird, Thomas Geoffrey ColerickKingston, John Francis, 24 Cornfield CloseWaterson, David
    • C07D407/04C07D317/46A61K31/36
    • C07D407/04C07D317/46
    • The invention concerns a bicyclic derivative of the formula I, or a pharmaceutically-acceptable salt thereof.
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      R¹ if (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a group of the formula -A¹-X-A²-, wherein each of A¹ and A² is (1-4C)alkylene and X is oxy, thio, sulphinyl, sulphonyl or imino.
      The invention also concerns processes for the manufacture of a bicyclic derivative of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said bicyclic derivatives. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的双环衍生物或其药学上可接受的盐。 其中Ar 1是任选取代的苯基或萘基; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 和R 2和R 3一起形成式-A 1 -XA 2 - 的基团,其中A 1和A 2各自为(1-4C)亚烷基和X 是氧基,硫基,亚磺酰基,磺酰基或亚氨基。 本发明还涉及制备式I的双环衍生物或其药学上可接受的盐以及含有所述双环衍生物的药物组合物的方法。 本发明的化合物是5-脂氧合酶的抑制剂。